Sanofi's Lemtrada Beats Rebif in MS Face-off - Apr. 25, 2012

Having trouble viewing this email? View in Browser.

Wednesday, April 25, 2012  |   |   |   |  Reduce Risk and Maximize Potential in Ophthalmology Development Ophthalmic study design and execution can be quite different than other therapeutic areas. Pharm-Olam's team has a proven track record of excellence in achieving trial objectives and can provide strategic, operational and consulting to sponsors for phase I to phase IV development. The majority of our clinical staff in emerging markets are MDs or PhDs, including Ophthalmologists in strategic areas for clinical trials. The incidence of disorders and standards of treatment can vary widely, so let Pharm-Olam conduct a complimentary feasibility study specific to your protocol and study budgets to use in your resource planning. Contact us at www.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0-1344-891121. •  Sanofi (France) (SAN.PA)'s Lemtrada Beats Rebif in MS Face-off More... •  Kythera Biopharmaceuticals Announces Positive Results from Two Pivotal European Phase III Trials of ATX-101 for Reduction of Submental Fat More... •  AVI BioPharma, Inc. (AVII) to Present Additional Data From the Phase IIb Study of Eteplirsen for the Treatment of Duchenne Muscular Dystrophy at the 2012 American Academy of Neurology Annual Meeting More... •  Repligen Corporation (RGEN) Reports Positive Results from Phase 1 Clinical Trial of RG3039 for Spinal Muscular Atrophy More... •  Ablynx Release: Nanobody for Alzheimer's Disease From the Alliance With Boehringer Ingelheim Corporation Moves Closer Towards Phase I Clinical Trials More... More Phase III News More Phase II News More Phase I News More Pre-Clinical News More Post-Approval News •  American Regent, Inc. Initiates Nationwide Voluntary Recall of Epinephrine Injection, USP, 1:1000, 1 mL Ampules Lot #1395 Due to Discoloration and Small Visible Particles More... More Discontinuations News More Recalls and Warning News •  Novartis AG (NVS) Drug SigniforR Gets EU Approval as the First Medication to Treat Patients With Cushing's Disease More... More Drug Approval News •  Salix Pharmaceuticals, Ltd. (SLXP), Progenics Pharmaceuticals, Inc. (PGNX) Announce FDA Extension of RELISTOR® sNDA Goal Date to July 27, 2012 More... More BLA/NDA/ANDA News More IND News More MAA News Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! •  Fish Oil Could be Therapy for Periodontal Disease, University of South Australia Reveals More... •  Botox Ingredient Has Limited Effect on Headaches, Medical College of Wisconsin Study More... •  Does Fatty Food Impact Marital Stress? Ohio State University Medical Center Study More... •  Signs of Early DNA "Aging" in Abused Kids, Duke University Study More... •  Evaluating the First Drug to Show Improvement in Subtype of Autism, Mount Sinai School of Medicine Study More... More General Clinical Research News Biomarkers in Late Stage Clinical Trials • Quantify and analyze revenues of late stage biomarker technology and services in North America, Europe, Asia and the Rest of the World. • Identify the key market drivers and resistors of the biomarker market and evaluate the growth potential of emerging technologies. • Assess biomarker activity at leading companies, including Abbott, AZ, BMS, Eli Lilly, GSK, Merck & Co, Novartis, Pfizer, Roche and Sanofi-Aventis. Click Here for More Information. The Biomarker World Congress 2012 is dedicated to all areas of biomarker research. The meeting brings together a mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers. For more information visit: www.BiomarkerWorldCongress.com. • BioCapital (Virginia Beach, Virginia) Cubist Pharmaceuticals, Inc. Clinical Business Manager Responsible for achieving and maximizing territory and account sales goals through account management, high level clinical proficiency and effective selling. The CBM will be the primary point of contact for Cubist with key hospital influencers and decision makers across key functional areas including but not limited to physicians, pharmacists and formulary committee members. • BioMidwest (Chicago, Illinois) Takeda Pharmaceuticals Associate Trial Manager, Phase 1 Operations Responsible for the execution of Phase 1 clinical studies according to ICH, GCP guideline, and required regional regulations as applicable in support of the clinical strategies defined in the Integrated Development Plan (IDP) • Rocky Bio (Phoenix, Arizona) Roche Diagnostics Clinical Specialist Will support all aspects of clinically focused sales for Roche's ACCU-CHEK product line, which includes blood glucose meters, insulin delivery systems, diabetes information management solutions, diabetes programs and services, and co-promoted product solutions within an assigned territory. • Pharm Country (Kinnelon, New Jersey) ClinAudits Manager Clinical GCP Compliance Operations Overseeing administrative and support functions such as continued communication with field auditors, employees, vendors and clients; scheduling and ensuring timely progress of workflow; managing databases; improving and enhancing workflow processes; and being a key part of the decision-making process. • Biotech Bay (Mountain View, California) MedImmune, LLC Associate Project Manager, Clinical Sample & Data Management Represents CS&DM on Clinical Project Teams and applicable sub-teams for assigned ongoing and upcoming clinical studies of varying complexity across Therapeutic Areas. Plan and coordinate CS&DM activities in support of pre-clinical and clinical trials. • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! BioCapital Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Mid-Atlantic region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • BioCapital Career Fair, Bethesda, MD April 25, 2012 • Pharm Country Career Fair, King Of Prussia, PA May 1, 2012 • BioNC Career Fair, Durham, NC May 2, 2012 • Biotech Bay Career Fair, Burlingame, CA May 29, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services •  VistaGen Therapeutics, Inc. Secures Key U.S. Patent Covering Stem Cell Technology Methods Used to Test Drug Candidates for Liver Toxicity More... •  Lpath, Inc. Receives First U.S. Patent for Anti-LPA Antibody, Lpathomab More... •  Metabolix, Inc. Awarded Two U.S. Patents for Technology to Produce Biobased Polymers and Industrial Chemicals More... •  BioLineRx Ltd. Announces Extension of Patent for BCM (BL-1040) by USPTO More... •  Marshall Edwards, Inc. (MSHL) Issued New Patent For Use Of Lead Drug Candidate ME-143 In Treating Cancer More... More Patent News •  Novartis AG (NVS)'s Gilenya Given Final Approval by UK's Cost Agency More... •  PuraMed BioScience Continues to Build Awareness for LipiGesic(R) M Through Media Campaigns More... •  New Products from Abbott Laboratories (ABT)'s EAS(R) Sports Nutrition Brand Help Athletes Improve Post-Workout Recovery and Meet Fitness Goals More... More Drug Product News Hot Company Genentech (Oceanside) One Antibody Way Oceanside, California 92056 U.S.A. Phone: 760-231-2440 Since 2005, Genentech has been expanding its facilities in Oceanside, about 35 miles north of San Diego. Today, the campus spans 60 acres and includes a multi-product, biotech manufacturing and clinical operations complex with six buildings totaling 500,000 square feet. More Company Profiles Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship ClinicaSpace 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 ClinicaSpace 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the ClinicaSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong ClinicaSpace.com - Clinical Trials. Clinical Research. Community. • ClinicaSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 ClinicaSpace http://www.clinicaspace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.